Evidence map›Paper›PMID 26457258›Full record

ArticleJournal of nephropathology2015

Occult hepatitis C virus infection in Iranian hemodialysis patients.

Ali Eslamifar, Amitis Ramezani, Hassan Ehteram, Effat Razeghi, Farrokhlagha Ahmadi, Manouchehr Amini, Mohammad Banifazl, Gelavizh Etemadi, Hossein Keyvani, Anahita Bavand and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of nephropathology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. [Current status of the prevalence, diagnosis, and treatment of hepatitis C in patients undergoing hemodialysis].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2017
    Article
  4. Occult HCV Infection: The Current State of Knowledge.Iranian Red Crescent medical journal · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Ali EslamifarClinical Research Department, Pasteur Institute of Iran, Tehran, Iran.
Amitis RamezaniClinical Research Department, Pasteur Institute of Iran, Tehran, Iran.
Hassan EhteramDepartment of Pathology, Faculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
Effat RazeghiNephrology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Farrokhlagha AhmadiNephrology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Manouchehr AminiNephrology Department, Tehran University of Medical Sciences, Tehran, Iran.
Mohammad BanifazlIranian Society for Support of Patients with Infectious Diseases, Tehran, Iran.
Gelavizh EtemadiChamran Hospital, Tehran, Iran.
Hossein KeyvaniDepartment of Virology, Iran University of Medical Sciences, Tehran, Iran.
Anahita BavandClinical Research Department, Pasteur Institute of Iran, Tehran, Iran.
Arezoo AghakhaniClinical Research Department, Pasteur Institute of Iran, Tehran, Iran.
Pasteur Institute of Iran · IRTehran University of Medical Sciences · IRIranian Center for Quantum Technologies · IRIran University of Medical Sciences · IRKashan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOccult hepatitis C virus (HCV) infection is defined as the presence of HCV-RNA in liver or peripheral blood mononuclear cells (PBMCs) in the absence of detectable hepatitis C antibody (anti-HCV) or HCV-RNA in the serum. Low concentrations of HCV-RNA may be detected in PBMCs of hemodialysis (HD) patients and this could have a great impact on the management of HD patients.

objectivesThe aim of this study was to detect the occult HCV infection in Iranian HD patients. PATIENTS AND

methodsA total of 70 anti-HCV negative HD patients from three dialysis units in Tehran, Iran were included in this study. In these cases, presence of HCV-RNA in plasma samples was tested by reverse transcriptase-nested polymerase chain reaction (RT-nested PCR). In cases with negative anti-HCV and plasma HCV-RNA, genomic HCV-RNA was checked in PBMC specimens by RT-nested PCR.

resultsSeventy anti-HCV negative HD patients were enrolled in the study. 32.85% and 1.43% of cases had elevated levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) respectively. 7.14% of patients had elevated levels of both ALT and AST. HCV-RNA was negative in plasma samples of all anti-HCV negative HD subjects. The genomic HCV-RNA was not detected in any PBMC samples of HD cases with negative anti-HCV and plasma HCV-RNA.

conclusionsOccult HCV infection was not detected in our HD patients despite of elevated levels of liver enzymes in some participants. Further studies involving larger number of HD patients are required to elucidate the rate of occult HCV infection in HD cases.

Indexed as

HCV-RNAHemodialysis (HD)Hepatitis C virus (HCV)

Identifiers

PMID26457258
PMCPMC4596295
OpenAlexW2302327857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.